Stock YPH ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Astellas Pharma Inc. Deutsche Boerse AG

Equities

YPH

JP3942400007

Market Closed - Deutsche Boerse AG
Other stock markets
 03:41:10 2024-07-12 pm EDT 		5-day change 1st Jan Change
9.346 EUR +2.39% Intraday chart for Astellas Pharma Inc. +3.73% -14.88%
Jul. 02 Astellas Pharma Inc. Announces the Center for Drug Evaluation of the China National Medical Products Administration Approves Xtandi (Enzalutamide) for the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer CI
Jun. 03 US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ASTELLAS PHARMA INC.
Other Pharmaceuticals
+2.39%+3.73%-14.88%-27.58%-25.23% 18.8B - - -
  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. YPH Stock
  5. Charts Astellas Pharma Inc.
  6. Relative Strength Chart